"Humira is [US]America's top-selling drug, and it treats rheumatoid arthritis ... AbbVie, the company [set up to hold patents on Humira] ... had filed for 247 patents on this drug, at the time the report was released in 2018, and 136 ... had been granted.
... because of that lengthened monopoly period ... the cost to [US]Americans is at least an extra US$14 billion."
#PritiKrishtel, Co-Executive Director, I-MAK, 2020